Whats new

Whats new.

Ladenburg Thalmann - 3Q FY2024: Bullish on Randomized Trial Readout; Reaffirm Buy, $8.30 PT (Analyst: Ahu Demir, PhD)

April 30th 2024

For a copy of this research report please contact your Ladenburg Thalmann advisor